Evaluating Impact of Azithromycin Mass Drug Administrations on Cause-specific Mortality and Antibiotic Resistance: Mortality Trial
Phase of Trial: Phase IV
Latest Information Update: 20 Dec 2018
Price : $35 *
At a glance
- Drugs Azithromycin (Primary)
- Indications Infections
- Focus Therapeutic Use
- Acronyms MORDORIMort
- 17 Dec 2018 Results published in the Clinical Infectious Diseases
- 12 Jan 2018 Status changed from recruiting to completed.
- 15 Mar 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov.